Patents by Inventor Qinbo Zhou

Qinbo Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10400237
    Abstract: The present disclosure provides compositions and methods of their use to impair angiogenesis in a patient to treat indications including, but not limited to, tumor growth, age-related macular degeneration, and metastasis. Also provided are compositions and methods for promoting angiogenesis in patients in need thereof.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: September 3, 2019
    Assignee: The Administrators of the Tulane Educational Fund
    Inventors: Shusheng Wang, Qinbo Zhou
  • Publication number: 20170275619
    Abstract: The present disclosure provides compositions and methods of their use to impair angiogenesis in a patient to treat indications including, but not limited to, tumor growth, age-related macular degeneration, and metastasis. Also provided are compositions and methods for promoting angiogenesis in patients in need thereof.
    Type: Application
    Filed: March 2, 2017
    Publication date: September 28, 2017
    Inventors: Shusheng WANG, Qinbo ZHOU
  • Patent number: 9598694
    Abstract: The present invention relates to the involvement of miR function in the development of age-related macular degeneration (AMD). It is shown that miR-23, miR-24 and/or miR-27 are involved in pathologic neovascularization in AMD, and that agonism (miR-24) and inhibition (miR23/27) of the function of these molecules blocks events contributing to development and progression of disease.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: March 21, 2017
    Assignees: The Board of Regents of the University of Texas System, The Administrators of the Tulane Educational Fund
    Inventors: Shusheng Wang, Eric Olson, Qinbo Zhou
  • Publication number: 20150087693
    Abstract: The present invention relates to the involvement of miR function in the development of age-related macular degeneration (AMD). It is shown that miR-23, miR-24 and/or miR-27 are involved in pathologic neovascularization in AMD, and that agonism (miR-24) and inhibition (miR23/27) of the function of these molecules blocks events contributing to development and progression of disease.
    Type: Application
    Filed: May 2, 2013
    Publication date: March 26, 2015
    Applicants: The Administrators of the Tulane Educational Fund, The Board of Regents of the University of Texas System
    Inventors: Shusheng Wang, Eric Olson, Qinbo Zhou